Atlas Trials

A Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous Pemphigoid

Clinical trial NCT04499235 · TERMINATED

Trial details

NCT number
NCT04499235
Sponsor
Alkahest, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Pemphigoid, Bullous
Start date
2020-01-30
Primary completion
2021-03-29
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.